Clinical Trials Browser

Phase 1 × Interventional × Melanoma, Cutaneous Malignant × Clear all

NCT05479812 2026-02-09

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

Phase 1 Active not recruiting

DermatologicGenitourinaryThoracic

Melanoma, Cutaneous Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms

NCT04620603 2025-11-06

Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer

Phase 1 Active not recruiting

DermatologicGenitourinary

Melanoma, Cutaneous Malignant, Carcinoma, Renal Cell